Ken Griffin Milestone Pharmaceuticals Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 15,900 shares of MIST stock, worth $22,896. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,900
Previous 3,300
381.82%
Holding current value
$22,896
Previous $5,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MIST
# of Institutions
43Shares Held
30.2MCall Options Held
32.8KPut Options Held
0-
Black Rock Inc. New York, NY4.97MShares$7.16 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.69 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.96 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$3.83 Million1.58% of portfolio
-
Lion Point Capital, LP New York, NY2.34MShares$3.37 Million6.61% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $43.2M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...